$3.51
-0.04[-1.13%]
At close: Apr 16
$3.51
0[0.00%]
After Hours: 6:27PM EDT
Allogene Therapeutics
(NASDAQ:ALLO)Allogene Therapeutics Stock (NASDAQ:ALLO), Earnings Estimates, EPS, and Revenue
Allogene Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 1
EPS Estimate
$-0.440
Quarterly Revenue Estimate
$30K
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$95K
Analyze the earnings history of Allogene Therapeutics using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 05/01/2024 | PM | ALLO | Q1 | -$0.68 | -$0.44 | — | — | $52.00K | $30.00K | — | — | Get Alert |
| 03/14/2024 | PM | ALLO | Q4 | -$0.67 | -$0.45 | -$0.43 | 4.44% | $26.00K | $20.00K | $21.00K | 5.00% | Get Alert |
| 11/02/2023 | PM | ALLO | Q3 | -$0.58 | -$0.52 | -$0.37 | 28.85% | $49.00K | $10.00K | $43.00K | 330.00% | Get Alert |
| 08/02/2023 | PM | ALLO | Q2 | -$0.52 | -$0.59 | -$0.53 | 10.17% | $86.00K | $70.00K | $44.00K | -37.14% | Get Alert |
| 05/03/2023 | PM | ALLO | Q1 | -$0.56 | -$0.62 | -$0.68 | -9.68% | $61.00K | $10.00K | $52.00K | 420.00% | Get Alert |
| 02/28/2023 | PM | ALLO | Q4 | -$0.54 | -$0.70 | -$0.66 | 5.71% | $51.00K | $60.00K | $47.00K | -21.67% | Get Alert |
| 11/02/2022 | PM | ALLO | Q3 | -$0.57 | -$0.64 | -$0.58 | 9.38% | $49.00K | $10.00K | $49.00K | 390.00% | Get Alert |
| 08/09/2022 | PM | ALLO | Q2 | -$0.53 | -$0.61 | -$0.52 | 14.75% | $44.00K | $10.00K | $86.00K | 760.00% | Get Alert |
| 05/04/2022 | PM | ALLO | Q1 | -$0.25 | -$0.58 | -$0.56 | 3.45% | $38.34M | — | $61.00K | — | Get Alert |
| 02/23/2022 | PM | ALLO | Q4 | -$0.53 | -$0.60 | -$0.54 | 10.00% | $0.00 | -$10.00K | $51.00K | 610.00% | Get Alert |
| 11/04/2021 | PM | ALLO | Q3 | -$0.52 | -$0.56 | -$0.57 | -1.79% | $0.00 | $10.00K | $49.00K | 390.00% | Get Alert |
| 08/04/2021 | PM | ALLO | Q2 | -$0.53 | -$0.55 | -$0.53 | 3.64% | $0.00 | — | $44.00K | — | Get Alert |
| 05/05/2021 | PM | ALLO | Q1 | -$0.50 | -$0.46 | -$0.25 | 45.65% | $0.00 | $13.92M | $38.34M | 175.47% | Get Alert |
| 02/25/2021 | PM | ALLO | Q4 | -$0.58 | -$0.56 | -$0.53 | 5.36% | $0.00 | $3.17M | $0.00 | -100.00% | Get Alert |
| 11/04/2020 | AM | ALLO | Q3 | -$0.50 | -$0.54 | -$0.52 | 3.70% | $0.00 | — | $0.00 | — | Get Alert |
| 08/05/2020 | AM | ALLO | Q2 | -$0.41 | -$0.54 | -$0.53 | 1.85% | $0.00 | — | $0.00 | — | Get Alert |
| 05/06/2020 | AM | ALLO | Q1 | -$0.32 | -$0.58 | -$0.50 | 13.79% | $0.00 | — | $0.00 | — | Get Alert |
| 02/27/2020 | AM | ALLO | Q4 | -$0.37 | -$0.68 | -$0.58 | 14.71% | $0.00 | — | $0.00 | — | Get Alert |
| 11/05/2019 | AM | ALLO | Q3 | -$10.71 | — | -$0.50 | — | $0.00 | — | $0.00 | — | Get Alert |
FAQ
When is Allogene Therapeutics (NASDAQ:ALLO) reporting earnings?
Allogene Therapeutics (ALLO) is scheduled to report earnings on May 1, 2024. The last reported earnings were for reported on March 14, 2024 for Q4.
What were the latest earnings per share (EPS) for Allogene Therapeutics (NASDAQ:ALLO)?
The Actual EPS was $-0.43, which beat the estimate of $-0.45.
What were Allogene Therapeutics’s (NASDAQ:ALLO) revenues?
The Actual Revenue was $21K, which beat the estimate of $20K.
Browse earnings estimates, EPS, and revenue on all stocks.